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ABSTRACT
Objective: The objective of this study was to develop and validate a simple, precise and accurate reverse phase high performance liquid chromatographic 
method for simultaneous estimation of dicyclomine hydrochloride, paracetamol, and mefenamic acid from multicomponent tablet dosage form.
Methods: The optimized chromatographic separation was achieved using a stationary phase of hypersil gold ODS- C18 (250 × 4.6 mm i.d, 5 μm 
particle size) column and mobile phase of acetonitrile: Methanol: Potassium dihydrogen phosphate buffer, pH adjusted to 4.5 with orthophosphoric 
acid (OPA) in the ratio of 50: 30: 20 (v/v/v) with a flow rate of 1 mL/minute. The ultraviolet detection was carried out at 260 nm.
Results: The retention times of paracetamol, dicyclomine hydrochloride and MEF were found to be 4.2, 6.1 and 3.4 minutes, respectively. The method 
was validated for linearity, precision, accuracy, and robustness. The developed method provided linear responses within the concentration ranges 
2-12 µg/mL for dicyclomine hydrochloride, 50-300 µg/mL for paracetamol, and 25-150 µg/mL for MEF. The % recovery obtained were found to be 
99.09-99.44% for dicyclomine hydrochloride, 99.22-99.51% for paracetamol, and 99.49-99.60 for MEF.
Conclusion: The proposed method enables rapid quantification and simultaneous analysis of all the drugs from commercial formulations without any 
interference of excipients. Hence, the developed method can be successfully applied for routine analysis of dicyclomine hydrochloride, paracetamol, 
and MEF in their combined tablet formulation.
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INTRODUCTION
Combination of dicyclomine hydrochloride (DCM), paracetamol 
(PARA), and mefenamic acid (MEF) are used for the treatment 
of periodic spasms, pain in abdomen, pain in stomach, intestinal 
cramps, irritable bowel syndrome, inability to control urine and other 
conditions. These drugs work by reducing muscle contractions and 
pain; increasing the pain threshold and increases the blood flow 
across the skin, heat loss, and sweating. Dicyclomine hydrochloride 
is a muscarinic antagonist used as an antispasmodic and in urinary 
incontinence. Chemically, dicyclomine hydrochloride is known as 
2-(diethylamino) ethyl 1-cyclohexylcyclohexane-1-carboxylate; 
hydrochloride. Paracetamol is used to treat mild to moderate 
pain (from headaches, menstrual periods, toothaches, backaches, 
osteoarthritis, or cold/flu aches and pains) and to reduce fever. 
Paracetamol chemically is 4-acetaminophenol. MEF is nonsteroidal 
anti-inflammatory drugs used as antipyretics, analgesics, and anti-
inflammatory agents. Chemically, MEF is 2-(2, 3-dimethylanilino) 
benzoic acid (Fig. 1a-c,) [1-4].
Literature survey reveals that many spectrophotometric 
methods [5-10], high performance liquid chromatography 
(HPLC) [11-24], high performance thin layer chromatography [25-29], 
liquid chromatography-mass spectrometry [30], and GC [31] based 
methods have been reported for estimation of these drugs alone as 
well as in combination with other drugs in pharmaceutical dosage 
forms. Reversed phase (RP-HPLC) method offer significant economic 
advantages over the techniques cited above. Therefore, this work was 
aimed to develop and validate a new RP-HPLC method for simultaneous 




Blue Cross Laboratories Ltd., Goa kindly supplied gift samples of 
dicyclomine hydrochloride and MEF. Paracetamol gift sample was 
obtained from Molychem Manufacturers and Importers of Laboratory 
Reagents and Fine Chemicals, Mumbai. All chemicals and reagents 
used were of analytical grade and purchased from Merck Chemicals, 
India. CYCLOPAM PLUS tablet formulation containing dicyclomine 
hydrochloride 20 mg, paracetamol 500 mg, and MEF 250 mg was 
procured from local market.
Instrumentation
Chromatographic separation was achieved using HPLC system consisted 
of Intelligent HPLC pump model (Jasco PU 2080 plus), an autosampler 
and ultraviolet-visible (UV/VIS) (Jasco UV 2075 plus) detector. The 
output signal was monitored and processed using Jasco Borwin 
version 1.5, LC-Net II/ADC software. Hypersil gold ODS- C18 (250 mm, 
4.6 mm id, 5 µm particle size) was used as the stationary phase. 
Mobile phase consisting acetonitrile: Methanol: Potassium dihydrogen 
phosphate buffer, pH adjusted to 4.5 with orthophosphoric acid 
(OPA) in the ratio of 50: 30: 20 (v/v/v) was delivered at a flow rate 
of 1 mL/minute. The detector was set at the wavelength of 260 nm. 
Injection volume was kept 20 µL.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Selection of wavelength
A UV spectrum of dicyclomine hydrochloride, paracetamol, and MEF in 
methanol was recorded by scanning the solution in the range of 200 nm 
to 400 nm. Dicyclomine hydrochloride, paracetamol, and MEF were 
showing significant absorption at wavelength 260 nm. Hence that was 
selected as the wavelength for analysis.
Preparation of standard stock solutions
A standard mixed stock solution of dicyclomine hydrochloride, 
paracetamol, and MEF was prepared by accurately weighing dicyclomine 
hydrochloride (20 mg), paracetamol (500 mg) and MEF (250 mg) into 
a 100 mL volumetric flask. The drugs were dissolved in acetone and the 
solution was diluted to volume. Stock solution was filtered through a 
0.45 μm membrane filter. The stock solution was further diluted with 
mobile phase to obtain a solution of DCM (2 μg/mL), PARA (50 μg/mL) 
and MEF (25 µg/mL), respectively.
Preparation of sample solution
About 20 tablets of the pharmaceutical formulation CYCLOPAM PLUS 
(containing 20 mg of DCM, 500 mg of PARA and 250 mg of MEF) were 
assayed. They were crushed to a fine powder, and an amount of the 
powder equivalent to 20 mg of DCM, 500 mg of PARA and 250 mg of 
MEF was weighed and transfer in a 100 mL volumetric flask. The 
powder obtained was dissolved in acetone. The volumetric flask was 
sonicated for 15 min to effect complete dissolution of the DCM, PARA 
and MEF; the solution was then made up to volume with mobile phase. 
The solution was filtered through Whatman filter paper. The aliquot 
portion of the filtrate was further diluted to get a final concentration of 
2 μg/mL of DCM 50 μg/mL of PARA and 25 μg/mL of MEF.
Method validation
The proposed method was validated for linearity, limit of detection 
(LOD) and limit of quantitation (LOQ), precision, accuracy and 
robustness as per International Conference on Harmonization (ICH) 
guideline [32].
Linearity
DCM (20 μg/mL), PARA (500 μg/mL) and MEF (250 μg/mL) stock 
solution was prepared, and it was diluted to prepare working 
standard solutions of 2-12 µg/mL of DCM, 50-300 µg/mL of PARA and 
25-150 μg/mL of MEF, respectively. These solutions were injected in 
triplicate into the column, and the chromatograms were recorded with 
the optimized chromatographic conditions. The calibration curves of 
the area versus concentration were recorded for the three drugs.
LOD and LOQ
The method is said to be sensitive if it detects very low concentration 
of the analyte. It is based on the LOD and LOQ values. ICH guideline 
specifies three different types of methods to determine the LOD and 
LOQ values which include visual evaluation signal to noise ratio, and the 
standard deviation of response and the slope of the calibration curve. In 
the current study, the LOD and LOQ were based on the second approach 
and were calculated according to S/N 3:1 and 10:1, respectively.
Precision
The precision of the method was determined by three independent 
injections of three different concentrations of each drug (4, 8, 12 μg/mL 
for DCM, 100, 200, 300 μg/mL for PARA and 50, 100, 150 μg/mL for 
MEF), which were injected on the same day (intra-day precision or 
repeatability), and the values of relative standard deviation (% RSD) 
were calculated. The same concentration solutions were injected on 
different days to determine interday precision.
Recovery studies
The accuracy of the method, expressed in terms of recovery studies, 
was performed by standard addition method by adding known amount 
of drug to the real samples. Samples were suitably diluted and injected 
at each concentration levels in triplicate.
Robustness of method
The robustness of the developed method was determined by altering 
the experimental conditions such as flow rate, pH and percentage 




The method development was finally optimized with the following 
conditions: Mobile phase consisting of acetonitrile: Methanol: Potassium 
dihydrogen phosphate buffer, pH adjusted to 4.5 with OPA in the ratio of 
50: 30: 20 (v/v/v) and hypersil gold ODS C-18 (250 mm × 4.6 mm; 5 μm 
particle size) column as stationary phase. The analysis was carried out 
in an isocratic elution mode using a flow rate of 1.0 mL/min, injection 
volume of 20 µL at room temperature, and the detection of analyte was 
recorded at 260 nm. The mobile phase solvents were filtered through 
0.45 μm member filter before delivering into the HPLC system. The 
selectivity of the method was performed by injecting the diluents and 
the mobile phase for any coeluting peaks, at retention times (Rt) of PARA, 
DCM and MEF were found to be 4.2, 6.1 and 3.4 minutes, respectively. 
The peak shape of all the drugs was satisfactory and suitable. Typical 
chromatograms are shown in Fig. 2 performance liquid chromatography 
chromatogram of dicyclomine, Paracetamol  and mefenamic acid.
System suitability
The system suitability test plays an important role in the development 
of chromatographic method; it was used to insure that, the system is 
working correctly. There are system suitability parameters such as Rt, 
peak area, theoretical plates (N), and tailing factor were checked. This 
test was performed during development of the method. This test was 
performed by injecting the standard mixture in 5 replicates (Table 1).
Validation of the developed hplc method
Linearity
The linearity range was established at 2-12 μg/mL for DCM, 
50-300 μg/mL for PARA and 25-150 μg/mL for MEF. The linear 
regression equations were Y = 11203X + 90.78 (r2 = 0.998) for DCM, 
Table 1: System suitability studies
Parameters DCM HCl PARA MEF
Rt (minute) 4.2 3.4 6.1
Asymmetry 1.156 1.173 1.345
Plates 4543 17445 4600
Area 113589 435140 115018
Tailing factor 1.4 1.2 1.7
Rt: Retention times, DCM: Dicyclomine, MEF: Mefenamic acid, PARA: 
Paracetamol DCM: Dicyclomine, MEF: Mefenamic acid
Fig. 1: (a) Chemical structure of dicyclomine hydrochloride, 
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Fig. 2: High performance liquid chromatography chromatogram of dicyclomine, PARA and mefenamic acid
Fig. 3: Calibration curve of dicyclomine
Fig. 4: Calibration curve of Paracetamol
Y = 44412X - 10223 (r2 = 0.998) for PARA and Y = 11478X - 11071 
(r2 = 0.997) for MEF. The plots obtained from linear regression are 
given in Figs. 3-5 for DCM, PARA and MEF, respectively.
LOD and LOQ
The LOD and LOQ were found to be 0.4 μg/mL and 1 μg/mL for DCM, 
15 μg/mL and 48 μg/mL for PARA and 5 μg/mL and 16 μg/mL for MEF, 
respectively, which indicate that the method was sensitive.
Precision
The intra- and inter-day precision studies showed a % RSD for DCM, 
PARA and MEF was <2%, respectively, which proved the method was 
sufficiently precise (Table 2).
Accuracy
Accuracy of the method was determined by applying the proposed 
method to synthetic mixture containing known amount of each drug to 
80%, 100%, and 120% of the label claim. The % recovery obtained was 
found to be in the range of 99.09-99.44% for DCM, 99.22-99.51% for 
PARA, and 99.49-99.60 for MEF. The results were summarized in Table 3.
Robustness
Robustness studies were conducted by adjusting flow rate 
(±0.1 mL/minute), percentage of methanol in mobile phase (±1%), 
Fig. 5: Calibration curve of mefenamic acid
and pH of buffer (±0.1). On changing these chromatographic conditions, 
the method was proven to be robust as there was no greater deviation 
in the Rt and peak shape (Table 4).
Analysis of the marketed formulation (assay)
The developed method was applied for the determination of DCM, PARA 
and MEF in tablet dosage form. The obtained result for DCM, PARA and 
MEF was comparable with a corresponding label claim. The % content 
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was calculated and found to be 99.57%, 99.71%, and 99.64% for DCM, 
PARA, and MEF, respectively.
CONCLUSION
A simple, accurate, and specific RP-HPLC method has been developed for 
quantitative determination of dicyclomine hydrochloride, paracetamol 
and MEF in bulk and pharmaceutical dosage form. The method was 
duly validated using required statistical parameters. From these 
results, it can be concluded that the proposed method is quite precise 
and accurate. The absence of additional peaks in the chromatogram 
indicated that there is no interference of the common excipients used 
in the tablets. The proposed HPLC method is sensitive and repeatable 
for the analysis of dicyclomine hydrochloride, paracetamol, and MEF in 
tablet dosage form.
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